Skip To Main Content
 

Incident and Prevalent counts by quarter

Incident counts of reported ESRD, 2016 Q1 - 2018 Q3
2016^ 2017^ 2018^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3
0 - 19 286 275 274 270 264 260 268 260 236 257 264
20 - 44 3,758 3,568 3,313 3,470 3,644 3,554 3,237 3,391 3,650 3,468 3,211
45 - 64 12,826 12,021 11,285 11,729 12,698 11,829 11,210 11,687 12,434 11,644 10,561
65 - 74 9,008 8,603 7,978 8,297 8,823 8,598 8,047 8,434 9,159 8,687 7,698
75 + 7,732 7,158 6,675 6,997 7,600 7,310 6,624 7,142 7,826 7,526 6,542
Male 19,608 18,192 17,020 17,876 19,306 18,308 17,099 18,014 19,650 18,434 16,292
Female 14,002 13,433 12,505 12,887 13,723 13,243 12,287 12,900 13,655 13,148 11,984
Diabetes 15,948 14,824 13,792 14,593 15,683 14,661 13,746 14,586 15,861 14,675 12,836
Hypertension 9,384 8,875 8,422 8,783 9,409 9,124 8,546 8,955 9,551 9,218 7,921
Glomerulonephritis 2,529 2,303 2,193 2,217 2,450 2,248 2,028 2,129 2,288 2,205 1,969
Cystic kidney 933 946 870 844 907 895 865 842 868 861 832
Other urologic 452 453 401 432 450 468 404 456 456 469 419
Other cause 3,339 3,304 2,986 3,057 3,132 3,167 2,867 2,964 3,139 2,873 2,568
Unknown cause 156 111 101 106 121 112 93 89 117 122 289
Missing cause 869 809 760 731 877 876 837 893 1,025 1,159 1,442
All 33,610 31,625 29,525 30,763 33,029 31,551 29,386 30,914 33,305 31,582 28,276

^ Data as of December 31, 2018
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Point prevalent counts of reported ESRD, 2016 Q1 - 2018 Q3
2016^ 2017^ 2018^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3
0 - 19 7,722 7,731 7,727 7,676 7,672 7,653 7,623 7,624 7,576 7,589 7,589
20 - 44 106,634 106,850 106,663 106,675 106,921 107,385 107,196 107,183 107,566 107,945 107,731
45 - 64 314,394 316,614 318,037 319,270 321,292 323,095 323,894 324,824 326,165 327,732 328,172
65 - 74 171,076 173,941 176,069 178,268 179,789 182,170 184,556 186,214 187,787 189,864 191,384
75 + 116,119 117,441 118,814 119,692 120,518 122,027 123,636 124,934 125,948 128,066 129,465
Male 414,018 417,891 420,764 423,506 426,464 430,481 433,563 436,048 438,987 442,867 444,752
Female 301,857 304,617 306,477 308,006 309,662 311,783 313,277 314,667 315,993 318,266 319,526
Unknown 70 69 69 69 66 66 65 64 62 63 63
Diabetes 274,660 277,695 279,766 281,590 283,698 286,277 288,084 289,555 291,148 293,489 294,230
Hypertension 183,360 185,284 186,890 188,364 189,680 191,546 193,134 194,480 195,921 197,964 198,902
Glomerulonephritis 114,191 114,649 115,001 115,285 115,665 116,068 116,252 116,524 116,856 117,322 117,476
Cystic kidney 34,092 34,579 34,985 35,376 35,753 36,160 36,573 36,917 37,247 37,598 37,892
Other urologic 11,652 11,781 11,845 11,953 12,022 12,143 12,205 12,305 12,387 12,526 12,606
Other cause 62,372 63,079 63,422 63,784 64,119 64,807 65,229 65,515 65,818 66,181 66,230
Unknown cause 23,796 23,370 22,934 22,481 22,061 21,679 21,331 20,955 20,589 20,318 20,226
Missing cause 11,822 12,140 12,467 12,748 13,194 13,650 14,097 14,528 15,076 15,798 16,779
All 715,945 722,577 727,310 731,581 736,192 742,330 746,905 750,779 755,042 761,196 764,341

^ Data as of December 31, 2018
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Reported Medical Evidence Form data for the incident ESRD population, 2016 Q1 - 2018 Q3
2016^ 2017^ 2018^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3
White 22,201 20,797 19,519 20,450 21,486 20,830 19,208 20,269 21,926 20,573 18,070
Black/African American 8,536 8,118 7,419 7,708 8,536 7,825 7,462 7,752 8,230 7,782 6,951
Native American/Alaska Native 306 326 292 287 327 292 264 306 302 348 315
Asian 1,427 1,301 1,220 1,303 1,459 1,361 1,271 1,309 1,412 1,380 1,227
Pacific Islander 421 407 396 361 397 393 351 393 419 358 314
Other/Unknown * * . . . * * * * * *
No ME Form 846 788 754 727 870 870 836 880 1,014 1,143 1,396
Hispanic 4,950 4,403 4,028 4,269 4,530 4,414 4,145 4,336 4,797 4,591 3,863
Non-Hispanic 27,941 26,547 24,817 25,839 27,675 26,288 24,411 25,694 27,493 25,850 23,014
Unknown * * * * . . * * * * *
No ME Form 846 788 754 727 870 870 836 880 1,014 1,143 1,396
Hemodialysis (%)1 90.32 89.79 89.16 90.27 90.23 89.26 88.92 89.3 89.27 88.17 87.84
CAPD (%)1 4.65 4.74 5.01 4.41 4.27 4.83 4.88 4.64 4.38 4.8 4.93
CCPD (%)1 5.02 5.45 5.81 5.29 5.49 5.9 6.18 6.05 6.34 7.02 7.22
Other (%)1 0.009 0.023 0.018 0.024 0.013 0.003 0.014 0.01 0.013 0.017 0.004
Unknown (%)1 . . . . . 0.007 . . . . .
Cathether Only (%)2 62.61 62.22 61.81 63.23 62.96 62.48 63.22 65.02 64.92 64.25 64.89
Catheter w/ maturing AVF (%)2 16.07 16.59 15.84 15.74 15.61 15.58 14.93 14.63 14.49 14.53 13.37
Catheter w/ maturing AVG (%)2 1.6 1.64 1.6 1.6 1.6 1.5 1.4 1.36 1.6 1.52 1.58
AVF (%)2 16.66 16.35 17.2 16.51 16.64 17.1 17.18 15.84 15.87 16.44 16.84
AVG (%)2 2.87 3.08 3.36 2.8 3.05 3.16 3.07 3.01 2.98 3.08 3.12
Other(%)2 0.15 0.088 0.18 0.12 0.13 0.16 0.18 0.12 0.1 0.15 0.13
Unknown(%)2 0.031 0.037 0.008 0.008 0.007 0.015 0.024 0.019 0.039 0.027 0.078
Pre-ESRD EPO(% Yes)3 19.88 19.9 20.15 20.26 20.05 21.2 21.14 21.12 21.73 22.53 23.36
Pre-ESRD Nephrology(% Yes)3 74.59 75.54 76.26 75.84 76.41 78.05 78.43 77.16 78.41 79.77 80.17
Mean Serum Albumin(g/dL)4 3.15 3.18 3.21 3.17 3.16 3.21 3.23 3.21 3.2 3.25 3.28
Mean Serum Creatinine(mg/dL)4 6.4 6.37 6.42 6.42 6.41 6.38 6.37 6.41 6.4 6.33 6.38
Mean Hemoglobin(g/dL)4 9.33 9.35 9.38 9.3 9.31 9.35 9.39 9.34 9.32 9.39 9.36
All 33,739 31,741 29,600 30,836 33,075 31,572 29,393 30,916 33,309 31,586 28,278
All with ME Form 32,893 30,953 28,846 30,109 32,205 30,702 28,557 30,036 32,295 30,443 26,882
Dialysis Pts with ME Form 32,311 30,306 28,228 29,469 31,588 30,045 27,908 29,344 31,619 29,764 26,262
Hemodialysis Pts w/ ME Form 29,182 27,213 25,169 26,603 28,503 26,817 24,817 26,203 28,226 26,242 23,069

^ Data as of December 31, 2018.
* Suppressed due to inadequate sample size.
. Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator 'Dialysis Patients with ME Form' counts.
2 Vascular access type percentages shown are based on denominator 'Hemodialysis Patients with ME Form' counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. 'Did patient receive exogenous erythropoetin or equivalent?''
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. 'Was patient under care of nephrologist?''
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator 'All with ME Form' counts.
4 Mean laboratory test values shown are based on denominator 'All with ME Form' counts.